Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Initial studies have investigated the association between inflammation and colorectal cancer (CRC) using C‐reactive protein (CRP) as a proinflammatory biomarker and have noted inconsistent results among women. We here report the findings from a large prospective study with repeat measurements of CRP, as well as serum amyloid A (SAA), an additional biomarker of inflammation, and risk of CRC. In the Women's Health Initiative Observational Study, we examined associations of CRP and SAA with CRC using repeat assessments (baseline and 3‐year follow‐up) among 953 matched case–control pairs for CRP and 966 pairs for SAA. Multivariate‐adjusted conditional‐logistic regression models were used with two‐sided tests of significance. Receiver operating characteristic (ROC) curve analysis assessed their utility as early detection markers. Colon cancer risk (odds ratio [OR] and 95% confidence intervals) among women in the highest quintiles of CRP or SAA compared to those in the lowest quintiles was OR colon/CRP = 1.37 (0.95–1.97, p‐trend = 0.04) and OR colon/SAA = 1.26 (0.88–1.80, p‐trend = 0.10), respectively. Women with elevated concentrations of both CRP and SAA had an increased risk of OR colon = 1.50 (1.12–2.00, p‐value = 0.006) compared to those with low concentrations. No positive associations were observed with rectal cancer and weaker associations for CRC overall. Temporal changes in biomarkers more than 3 years did not predict risk. The area under the 6‐month ROC curve for CRP+SAA was 0.62 (95% confidence interval = 0.55–0.68). Elevated inflammatory biomarkers are associated with an increased risk of CRC, mainly colon cancer. Nevertheless, changes in the biomarkers over time do not suggest that they merit consideration as early detection markers for CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 2×
“C-reactive protein (CRP) and serum amyloid A (SAA) are nonspecific hepatic inflammatory markers produced in response to infection, trauma and other inflammatory states.(9,10) Acutely, their serum concentrations increase and slowly return to normal over some days.”
BackgroundRothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Il'yasova, D., Colbert, L. H., Harris, T. B., Newman, A. B., Bauer, D. C., Satterfield, S., & Kritchevsky, S. B. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0316 · Cited by 479
Cited by
Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review
Phillips, C. M., Chen, L.-W., Heude, B., Bernard, J. Y., Harvey, N. C., Duijts, L., Mensink-Bout, S. M., Polanska, K., Mancano, G., Suderman, M., et al. (2019) · Nutrients · doi:10.3390/nu11081873 · Cited by 337
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253
“Cases and controls were matched on age (±3 y), race/ethnicity, timing of baseline 67 blood draw (±6 months), enrollment date (±1 y) and baseline hysterectomy status (11, 22).”
Self-citationMeydani, S. N., Das, S. K., Pieper, C. F., Lewis, M. R., Klein, S., Dixit, V. D., Gupta, A. K., Villareal, D. T., Bhapkar, M., Huang, M., et al. (2016) · Aging · doi:10.18632/aging.100994 · Cited by 228
“The WBC count has been broadly used as a non-specific marker of systemic inflammation [23], with higher levels, even when within the clinical reference range, associated with an increased risk of developing insulin resistance, T2D [24], hypertension [25], CVD [26], and cancer [27].”
BackgroundTabung, F. K., Steck, S. E., Ma, Y., Liese, A. D., Zhang, J., Caan, B., Hou, L., Johnson, K. C., Mossavar-Rahmani, Y., Shivappa, N., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-014-0515-y · Cited by 193
“between inflammation and colon cancer is further supported by evidence from studies showing a positive association between higher concentrations of inflammatory biomarkers and increased risk of colon cancer [49–51], or a reduced risk of colon cancer with regular use of NSAIDs [7–9].”
Result
Metadata
- Authors
- Toriola, A. T., Cheng, T. D., Neuhouser, M. L., Wener, M. H., Zheng, Y., Brown, E., Miller, J. W., Song, X., Beresford, S. A. A., Gunter, M. J., Caudill, M. A., & Ulrich, C. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2012-12-05
- Volume
- 132
- Issue
- 11
- Pages
- 2648-2658
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2080748385
- Cited by
- 86
- References
- 4
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.